<DOC>
	<DOCNO>NCT00137020</DOCNO>
	<brief_summary>The primary objective compare effectiveness ziprasidone treatment current treatment ( haloperidol , olanzapine risperidone ) measure change Brief Psychiatric Rating Scale ( BPRS ) score versus baseline</brief_summary>
	<brief_title>Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Primary diagnosis schizophrenia schizoaffective disorder , use DSMIV criterion . Currently receive either haloperidol , olanzapine risperidone within /+ 25 % recommend daily dose ( delineated medication 's package insert Resistance conventional antipsychotic drug With antipsychotic agent olanzapine , risperidone haloperidol start treatment regimen within 12 hour prior first dose study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2006</verification_date>
</DOC>